Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The…
Earnings galore too. $AAPL $PLTR $VRTX $MAR $ON $FOXA $ROKU $AMD $AMGN $SHOP $PFE $ETN $BKNG $RACE $APO $KDP $XYZ $YUM $SYY $ARM $QCOM $NVO $MCD $UBER $CVS $MCK $DDOG $APP $ALL $MET $AFL $CRCL Barron's/Dow Jones owner $NWSA $COP $SONY $MNST $ABNB $LITE $MRNA $HUM $VST + many more
$HUM Back test of top of Oct Value Area https://t.co/Vi5Y1dGLpR
$HUM has been a basket case and we bailed early this year once the $CCP bid and activist campaign fell apart I don’t believe Drew needs to be on the board anymore He has shown he can just block any bid. He’s in control effectively. He might not be able to block a sale of a
$HUM up 12% today on Medicare star ratings, of all things. 95% of Humana's Medicare Advantage members land in 4 star or higher plans for 2027, up from 20% this year. Whats overlooked is 4 stars is where the government bonus money kicks in. Evercore puts it at $4.8B for 2028.…
Humana $HUM is up 14.4% premarket after 2027 Medicare Advantage star ratings showed 95% of its members are in plans rated 4 stars or higher, per Reuters Higher ratings bring government bonus payments, and Oppenheimer estimates the improved scores could add $3.6 billion in…
@toy59496 @puppyeh1 $HUM is uninvestable atm The founder won this battle and it’s an avoid
26 analysts rate HUM Buy on consensus.
Consensus price target: $465.12 (+13.33% upside from $410.41)
| Insider | Date | Transaction | Shares | Value |
|---|---|---|---|---|
| Shetty Sanjay K President, CenterWell | Feb 23, 2026 | Purchase | 810 | $150.02K |
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2025 | $129.66B | +10.06% | $1.19B |
| 2024 | $117.81B | +10.68% | $1.21B |
| 2023 | $106.44B | +14.55% | $2.49B |
Stock data for HUM: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics